Cascade Catalytically Released Nitric Oxide-Driven Nanomotor with Enhanced Penetration for Antibiofilm

Small. 2022 Dec;18(52):e2205252. doi: 10.1002/smll.202205252. Epub 2022 Nov 7.

Abstract

Nanodrugs are becoming increasingly important in the treatment of bacterial infection, but their low penetration ability to bacterial biofilm is still the main challenge hindering their therapeutic effect. Herein, nitric oxide (NO)-driven nanomotor based on L-arginine (L-Arg) and gold nanoparticles (AuNPs) loaded dendritic mesoporous silica nanoparticles (AG-DMSNs) is fabricated. AG-DMSNs have the characteristics of cascade catalytic reaction, where glucose is first catalyzed by the asymmetrically distributed AuNPs with their glucose oxidase (GOx)- mimic property, which results in unilateral production of hydrogen peroxide (H2 O2 ). Then, L-Arg is oxidized by the produced H2 O2 to release NO, leading to the self-propelled movement. It is found that the active movement of nanomotor promotes the AG-DMSNs ability to penetrate biofilm, thus achieving good biofilm clearance in vitro. More importantly, AG-DMSNs nanomotor can eliminate the biofilm of methicillin-resistant Staphylococcus aureus (MRSA) in vivo without causing damage to normal tissues. This nanomotor provides a new platform for the treatment of bacterial infections.

Keywords: antibiofilms; enhanced penetration to biofilms; nanomotors; nitric oxide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections* / drug therapy
  • Biofilms
  • Gold / pharmacology
  • Humans
  • Metal Nanoparticles*
  • Methicillin-Resistant Staphylococcus aureus*
  • Nitric Oxide

Substances

  • Nitric Oxide
  • Gold
  • Anti-Bacterial Agents